One-Year Outcomes in Patients With Secondary MR Outside the COAPT Criteria: From the MitraClipTM Global EXPAND Study

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; Medtronic; NeoChord
• Physician advisory board member (unpaid) (Personal) - JenaValve